 Matthew Stone
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 10 | 2022 | 414 | 3.630 |
Why?
| | Heart Septal Defects, Ventricular | 3 | 2022 | 40 | 2.010 |
Why?
| | Ventricular Outflow Obstruction | 2 | 2022 | 38 | 1.590 |
Why?
| | Computed Tomography Angiography | 2 | 2023 | 100 | 1.590 |
Why?
| | Aortic Diseases | 3 | 2022 | 109 | 1.510 |
Why?
| | Double Outlet Right Ventricle | 2 | 2022 | 9 | 1.450 |
Why?
| | Ventricular Dysfunction, Left | 4 | 2022 | 371 | 1.410 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 269 | 1.260 |
Why?
| | Heart Transplantation | 4 | 2023 | 670 | 1.160 |
Why?
| | Fontan Procedure | 4 | 2023 | 168 | 1.120 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2021 | 114 | 1.020 |
Why?
| | Postoperative Complications | 7 | 2020 | 2122 | 0.980 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 477 | 0.960 |
Why?
| | Heart Defects, Congenital | 4 | 2023 | 683 | 0.910 |
Why?
| | Central Venous Catheters | 2 | 2022 | 40 | 0.860 |
Why?
| | Coronary Circulation | 2 | 2022 | 134 | 0.830 |
Why?
| | Aortic Coarctation | 1 | 2023 | 70 | 0.830 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 83 | 0.820 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 20 | 0.810 |
Why?
| | Fibroma | 1 | 2022 | 21 | 0.800 |
Why?
| | Atrioventricular Block | 1 | 2022 | 37 | 0.790 |
Why?
| | Hemodynamics | 3 | 2021 | 1015 | 0.780 |
Why?
| | Heart Neoplasms | 1 | 2022 | 49 | 0.780 |
Why?
| | Aorta, Thoracic | 2 | 2023 | 257 | 0.780 |
Why?
| | Echocardiography | 1 | 2023 | 569 | 0.730 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 6 | 0.720 |
Why?
| | Coronary Vessels | 1 | 2022 | 234 | 0.710 |
Why?
| | Child | 19 | 2023 | 18408 | 0.700 |
Why?
| | Coronary Angiography | 1 | 2022 | 308 | 0.690 |
Why?
| | Surgical Wound Infection | 1 | 2022 | 246 | 0.690 |
Why?
| | Tissue and Organ Procurement | 1 | 2022 | 226 | 0.650 |
Why?
| | Vascular Stiffness | 2 | 2020 | 410 | 0.640 |
Why?
| | Infant | 9 | 2023 | 7945 | 0.620 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 29 | 0.620 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2018 | 3 | 0.620 |
Why?
| | Predictive Value of Tests | 2 | 2023 | 1791 | 0.620 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 56 | 0.600 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 176 | 0.590 |
Why?
| | Nicardipine | 1 | 2017 | 6 | 0.590 |
Why?
| | Septal Occluder Device | 1 | 2018 | 46 | 0.580 |
Why?
| | Laparoscopy | 2 | 2012 | 395 | 0.570 |
Why?
| | Calcium Channel Blockers | 1 | 2017 | 113 | 0.560 |
Why?
| | Heart Ventricles | 5 | 2023 | 723 | 0.550 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 545 | 0.540 |
Why?
| | Respiration, Artificial | 1 | 2019 | 528 | 0.510 |
Why?
| | Humans | 43 | 2023 | 114077 | 0.490 |
Why?
| | Aortic Valve | 3 | 2023 | 397 | 0.450 |
Why?
| | Retrospective Studies | 11 | 2023 | 12521 | 0.450 |
Why?
| | Surgical Procedures, Operative | 2 | 2013 | 206 | 0.440 |
Why?
| | Catheters, Indwelling | 1 | 2013 | 74 | 0.420 |
Why?
| | Infant, Newborn | 6 | 2023 | 5038 | 0.400 |
Why?
| | Ethics, Medical | 1 | 2012 | 69 | 0.400 |
Why?
| | Treatment Outcome | 11 | 2022 | 9050 | 0.400 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2012 | 6 | 0.390 |
Why?
| | Peritoneal Dialysis | 1 | 2013 | 84 | 0.390 |
Why?
| | Coronary Sinus | 1 | 2012 | 7 | 0.390 |
Why?
| | Pericardium | 1 | 2012 | 50 | 0.380 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 25 | 0.380 |
Why?
| | Health Resources | 1 | 2013 | 120 | 0.380 |
Why?
| | Renal Insufficiency | 1 | 2013 | 137 | 0.380 |
Why?
| | Hernia, Diaphragmatic | 1 | 2011 | 68 | 0.370 |
Why?
| | Child, Preschool | 8 | 2022 | 9120 | 0.360 |
Why?
| | Male | 24 | 2023 | 55418 | 0.360 |
Why?
| | Diagnostic Errors | 1 | 2012 | 150 | 0.360 |
Why?
| | Suture Techniques | 1 | 2011 | 115 | 0.360 |
Why?
| | Tobacco Products | 2 | 2022 | 98 | 0.360 |
Why?
| | Insurance, Health | 1 | 2013 | 243 | 0.360 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2012 | 175 | 0.350 |
Why?
| | Hypertension | 1 | 2017 | 1052 | 0.330 |
Why?
| | Hospital Mortality | 2 | 2013 | 773 | 0.330 |
Why?
| | Tetralogy of Fallot | 2 | 2020 | 81 | 0.320 |
Why?
| | Female | 23 | 2023 | 59347 | 0.310 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 270 | 0.310 |
Why?
| | Incidence | 5 | 2022 | 2314 | 0.300 |
Why?
| | Smoking Cessation | 2 | 2022 | 374 | 0.300 |
Why?
| | Aorta | 4 | 2020 | 388 | 0.290 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 172 | 0.260 |
Why?
| | Adenocarcinoma | 1 | 2012 | 787 | 0.250 |
Why?
| | Heart | 2 | 2020 | 613 | 0.250 |
Why?
| | Pulmonary Artery | 3 | 2020 | 1024 | 0.240 |
Why?
| | Product Labeling | 2 | 2022 | 5 | 0.240 |
Why?
| | Time Factors | 6 | 2022 | 6077 | 0.240 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2023 | 40 | 0.230 |
Why?
| | Jugular Veins | 2 | 2022 | 38 | 0.220 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 27 | 0.210 |
Why?
| | Sternotomy | 1 | 2022 | 18 | 0.210 |
Why?
| | Fetal Diseases | 1 | 2023 | 146 | 0.200 |
Why?
| | Risk Factors | 6 | 2022 | 8612 | 0.200 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 104 | 0.190 |
Why?
| | Adolescent | 6 | 2021 | 17811 | 0.190 |
Why?
| | Trachea | 2 | 2021 | 223 | 0.180 |
Why?
| | Cardiopulmonary Bypass | 1 | 2022 | 174 | 0.180 |
Why?
| | Waiting Lists | 1 | 2022 | 206 | 0.180 |
Why?
| | Norwood Procedures | 1 | 2021 | 22 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 380 | 0.170 |
Why?
| | Cigarette Smoking | 1 | 2021 | 74 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 71 | 0.170 |
Why?
| | Young Adult | 4 | 2020 | 10458 | 0.170 |
Why?
| | Cannula | 1 | 2018 | 17 | 0.160 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 179 | 0.160 |
Why?
| | Recurrence | 1 | 2021 | 925 | 0.160 |
Why?
| | Calcinosis | 1 | 2021 | 239 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 687 | 0.150 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 669 | 0.150 |
Why?
| | Smoking | 2 | 2022 | 1382 | 0.140 |
Why?
| | Heart-Assist Devices | 2 | 2012 | 500 | 0.130 |
Why?
| | Case-Control Studies | 2 | 2021 | 3007 | 0.130 |
Why?
| | Reproducibility of Results | 1 | 2022 | 2764 | 0.120 |
Why?
| | Research Design | 1 | 2020 | 919 | 0.120 |
Why?
| | Double-Blind Method | 1 | 2018 | 1656 | 0.120 |
Why?
| | Pandemics | 1 | 2022 | 1311 | 0.120 |
Why?
| | Risk Assessment | 3 | 2019 | 2958 | 0.110 |
Why?
| | Rural Health | 1 | 2013 | 67 | 0.110 |
Why?
| | Hospital Charges | 1 | 2013 | 39 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 1 | 2013 | 66 | 0.100 |
Why?
| | Anxiety | 1 | 2019 | 844 | 0.100 |
Why?
| | Catheterization | 1 | 2013 | 158 | 0.100 |
Why?
| | Risk Adjustment | 1 | 2013 | 76 | 0.100 |
Why?
| | Tricuspid Valve | 1 | 2012 | 27 | 0.100 |
Why?
| | Medically Uninsured | 1 | 2013 | 122 | 0.100 |
Why?
| | Perfusion | 1 | 2012 | 147 | 0.100 |
Why?
| | Sirolimus | 1 | 2013 | 181 | 0.100 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 51 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2322 | 0.100 |
Why?
| | Cryosurgery | 1 | 2012 | 50 | 0.090 |
Why?
| | Mitral Valve | 1 | 2012 | 94 | 0.090 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2012 | 182 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 281 | 0.090 |
Why?
| | Medicare | 2 | 2013 | 661 | 0.090 |
Why?
| | Esophagectomy | 1 | 2012 | 110 | 0.090 |
Why?
| | Logistic Models | 2 | 2013 | 1830 | 0.090 |
Why?
| | Age Factors | 1 | 2017 | 2886 | 0.090 |
Why?
| | Linear Models | 1 | 2013 | 768 | 0.090 |
Why?
| | Positron-Emission Tomography | 1 | 2012 | 260 | 0.090 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2013 | 359 | 0.090 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 153 | 0.090 |
Why?
| | Lung Transplantation | 1 | 2012 | 244 | 0.090 |
Why?
| | Intensive Care Units | 1 | 2014 | 614 | 0.090 |
Why?
| | Prospective Studies | 2 | 2018 | 6198 | 0.090 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2012 | 201 | 0.080 |
Why?
| | Systole | 2 | 2020 | 176 | 0.080 |
Why?
| | Health Care Costs | 1 | 2012 | 381 | 0.080 |
Why?
| | Radiography | 1 | 2012 | 803 | 0.080 |
Why?
| | Cattle | 1 | 2012 | 918 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1422 | 0.080 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2011 | 184 | 0.080 |
Why?
| | Medicaid | 1 | 2013 | 404 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2010 | 162 | 0.080 |
Why?
| | Length of Stay | 1 | 2013 | 957 | 0.080 |
Why?
| | Cohort Studies | 3 | 2023 | 4884 | 0.070 |
Why?
| | Databases, Factual | 1 | 2013 | 1127 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1331 | 0.070 |
Why?
| | Stroke Volume | 2 | 2020 | 513 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2014 | 4392 | 0.070 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 492 | 0.070 |
Why?
| | Prognosis | 1 | 2012 | 3315 | 0.060 |
Why?
| | United States | 3 | 2021 | 12144 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2023 | 3862 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2010 | 637 | 0.060 |
Why?
| | Middle Aged | 7 | 2021 | 26620 | 0.050 |
Why?
| | Aged | 6 | 2021 | 18973 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 143 | 0.050 |
Why?
| | Virginia | 2 | 2014 | 50 | 0.050 |
Why?
| | Receptors, KIR | 1 | 2023 | 92 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2273 | 0.050 |
Why?
| | Adult | 5 | 2021 | 30394 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 296 | 0.050 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 152 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 310 | 0.050 |
Why?
| | Smokers | 1 | 2022 | 129 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 556 | 0.050 |
Why?
| | Acrocephalosyndactylia | 1 | 2021 | 10 | 0.050 |
Why?
| | Tobacco Use | 1 | 2021 | 60 | 0.050 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 33 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3039 | 0.050 |
Why?
| | Lung | 1 | 2012 | 3521 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 1958 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 37 | 0.040 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2020 | 34 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 177 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 182 | 0.040 |
Why?
| | Signal Transduction | 2 | 2023 | 4501 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 141 | 0.040 |
Why?
| | Regional Blood Flow | 1 | 2021 | 421 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1361 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2020 | 318 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 911 | 0.040 |
Why?
| | Blotting, Western | 1 | 2021 | 1143 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 387 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 224 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2020 | 256 | 0.040 |
Why?
| | Animals | 3 | 2013 | 31570 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 727 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2388 | 0.030 |
Why?
| | RNA | 1 | 2021 | 806 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2013 | 3499 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3397 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 74 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 78 | 0.030 |
Why?
| | Warm Ischemia | 1 | 2012 | 11 | 0.030 |
Why?
| | Citrates | 1 | 2012 | 42 | 0.030 |
Why?
| | Sus scrofa | 1 | 2012 | 45 | 0.030 |
Why?
| | Cost Savings | 1 | 2012 | 74 | 0.030 |
Why?
| | Organ Preservation Solutions | 1 | 2012 | 37 | 0.030 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 117 | 0.020 |
Why?
| | Reoperation | 1 | 2014 | 513 | 0.020 |
Why?
| | Cold Ischemia | 1 | 2012 | 27 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 99 | 0.020 |
Why?
| | Cold Temperature | 1 | 2012 | 125 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 377 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 229 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2012 | 522 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 221 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5503 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2012 | 283 | 0.020 |
Why?
| | Survival Rate | 1 | 2014 | 1638 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1144 | 0.020 |
Why?
| | Tissue Donors | 1 | 2012 | 314 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 368 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 2012 | 252 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 544 | 0.020 |
Why?
| | Vasoconstrictor Agents | 1 | 2010 | 113 | 0.020 |
Why?
| | Survival Analysis | 1 | 2012 | 1206 | 0.020 |
Why?
| | Risk | 1 | 2012 | 810 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2012 | 475 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 150 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2012 | 735 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1218 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 863 | 0.020 |
Why?
| | Heart Arrest | 1 | 2012 | 293 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4598 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 319 | 0.020 |
Why?
| | Contrast Media | 1 | 2010 | 347 | 0.020 |
Why?
| | Odds Ratio | 1 | 2010 | 951 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1078 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1128 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 4682 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 6307 | 0.010 |
Why?
| | Mice | 1 | 2013 | 14847 | 0.010 |
Why?
|
|
Stone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|